
Diclofenac Extended-Release Tablets
Form: Extended-Release Tablets
Strength: 100 mg
Reference Brands: Voltaren(US & EU)
Category: Arthritis
Diclofenac ER (Extended-Release) tablets are approved in the EU and US for managing chronic pain and inflammation. In the EU, brands like Voltaren ER are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments, with generic versions available. Both regions require detailed dossiers for approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We help facilitate efficient market access for diclofenac ER tablets, ensuring adherence to European and American standards for safe, effective long-term anti-inflammatory therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Pegloticase injecatble
Strength: 8 mg/1.2 mL vial
Form: Injectable (IV solution)
Reference Brands: Krystexxa (US)
View Details Get EnquiryColchicine tablest
Strength: 0.6 mg
Form: Tablet
Reference Brands: Colcrys(US)
View Details Get EnquiryFebuxostat tablets
Strength: 40 mg, 80 mg
Form: Oral Tablets
Reference Brands: Uloric(EU & US)
View Details Get EnquiryAllopurinol tablets
Strength: 100 mg, 300 mg
Form: Oral Tablets
Reference Brands: Aloprim(US & EU)
View Details Get Enquiry